SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Falls 4.21% Today

SAI LIFE SCIENCES LIMITED Share Price Today fell to Rs 1,355.6, down 4.21%, taking the stock into focus as a Large Cap top decliner with market capitalisation of Rs 29,580.11 crore.

SAI LIFE SCIENCES LIMITED Share Price came under pressure in today’s session, falling to Rs 1,355.6 from the previous close of Rs 1,415.25, a decline of Rs 59.65 or 4.21%. With market capitalisation at Rs 29,580.11 crore, the move is notable in the context of the stock’s Large Cap classification and its appearance among today’s top decliners. For investors tracking SAI LIFE SCIENCES LIMITED Share Price Today, the supplied data confirms a clear price fall and elevated market attention, even though it does not establish a company-specific catalyst behind the decline.

The stock opened at Rs 1,360.75, which also marked the day’s high, and then moved down to an intraday low of Rs 1,319.3 before trading at Rs 1,355.6 at the time of the update. That pattern matters because it shows that the early session failed to build upside follow-through and instead remained under selling pressure. In Stock Market Today and Share Market Today discussions, such price action often brings a stock into market movers lists, especially when the decline is large enough to trigger event-based screening.

For readers looking for SAI LIFE SCIENCES LIMITED Stock News, the immediate story is simple and factual: the share price decline has been sharp enough to make the stock trend in today’s market news flow. Beyond that, the most useful approach is to examine the trading pattern, volume participation, sector backdrop, peer positioning and what investors should monitor next on Univest.

SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,355.6
Previous Close	Rs 1,415.25
Today's Change	Rs -59.65 (-4.21%)
Day Open	Rs 1,360.75
Day High	Rs 1,360.75
Day Low	Rs 1,319.3
Current Volume (BSE)	11,751
BSE Traded Volume	11,751
NSE Traded Volume	1,01,340
Combined NSE + BSE Volume	1,13,091
Turnover	Rs 1.59 crore
Market Capitalisation	Rs 29,580.11 crore
Market Cap Category	Large Cap

SAI LIFE SCIENCES LIMITED (SAILIFE) traded at Rs 1,355.6. versus the previous close of Rs 1,415.25, a fall of 4.21%. The stock opened at Rs 1,360.75, reached Rs 1,360.75, touched Rs 1,319.3. Reported volume was 11,751.

SAI LIFE SCIENCES LIMITED (SAILIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 29,580.11 crore

SAI LIFE SCIENCES LIMITED Fundamental Analysis, based strictly on the supplied data, begins with scale. The company’s market capitalisation is Rs 29,580.11 crore, which places it far above the Healthcare sector benchmark median market capitalisation of Rs 140.58 crore and the benchmark average of Rs 471.12 crore across 198 companies in the same sector. That gap does not by itself say whether the stock is cheap or expensive, but it does show that the market assigns this company a far larger equity value than the typical listed Healthcare name in the supplied benchmark set.

That size differential is also important for how investors interpret a one-day move. A 4.21% decline in a company valued at Rs 29,580.11 crore represents a meaningful market move in percentage terms because large-cap stocks generally draw institutional and broad market attention. In Univest’s stock analysis framework, this means the event deserves to be looked at through sector positioning and relative listed-company context rather than through price action alone.

The supplied dataset does not provide company-specific valuation multiples such as P/E, P/B or EV/EBITDA for SAI LIFE SCIENCES LIMITED, nor does it include company profitability ratios like ROE and ROCE. As a result, the most grounded form of fundamental interpretation here is comparative rather than absolute. The company’s current market value is substantially above every named peer in the benchmark list, where the largest peer shown is Dishman Carbogen Amcis Ltd. at Rs 3,060.41 crore and the next several companies range between Rs 2,127.68 crore and Rs 2,862.43 crore.

That makes SAI LIFE SCIENCES LIMITED Share Price a stock that sits in a very different size bracket from the peer set included in the supplied Healthcare snapshot. For investors following SAI LIFE SCIENCES LIMITED Financial Results, SAI LIFE SCIENCES LIMITED Earnings and broader company financials, the key takeaway from today’s move is that scale is already significant. In Univest’s view, that means future market reactions are likely to be judged not only by direction, but also by whether price moves align with sector valuation context and the company’s relative standing within listed Healthcare names.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.27x
Benchmark Average P/E	92.32x
Benchmark P/E Range	3.3x to 3,493.04x
Benchmark Median P/B	1.95x
Benchmark Median ROE	10.77%
Benchmark Median ROCE	13.35%
Company Market Capitalisation	Rs 29,580.11 crore
Benchmark Median Market Cap	Rs 140.58 crore

SAI LIFE SCIENCES LIMITED (SAILIFE) is classified under sector: Healthcare.

Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

The Healthcare sector backdrop provides useful context for SAI LIFE SCIENCES LIMITED Share Price because today’s decline happened against a benchmark universe of 198 companies in the same sector. The supplied benchmark shows wide variation in valuation and profitability, which means sector context can help investors understand where market expectations tend to sit even when a company-specific catalyst is not established.

Within this Healthcare benchmark, the median P/E is 26.27 and the average P/E is 92.32, based on 156 companies, with a minimum of 3.3 and a maximum of 3,493.04. That very broad range suggests the sector includes both mature and highly re-rated businesses, as well as companies with sharply different earnings profiles. For price-based market news, that matters because a share price decline in a Healthcare stock may be read differently depending on where investors believe it sits within that valuation spectrum.

The benchmark P/B median stands at 1.95 and the average is 2.55 across 197 companies, with the range stretching from -21.27 to 16.42. On profitability, the benchmark ROE median is 10.77 and the average is 15.32, while ROCE median is 13.35 and average is 17.69, each based on 197 companies. These figures show that the Healthcare pack is not uniform; it contains low-return, high-return, low-multiple and high-multiple names all at once.

Market capitalisation dispersion is similarly large. The benchmark median market cap is Rs 140.58 crore, the average is Rs 471.12 crore, the minimum is Rs 4.29 crore and the maximum is Rs 3,060.41 crore. Against that backdrop, SAI LIFE SCIENCES LIMITED Market Cap at Rs 29,580.11 crore stands out dramatically. In other words, whatever today’s price fall signals in the short term, the stock remains in a very different scale category from the benchmark sample. Univest readers tracking SAI LIFE SCIENCES LIMITED Share Price Live should therefore read today’s decline in the context of a company whose listed value is many times larger than the sector benchmark scope supplied here.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,060.41	31.3	0.46	-2.89	-0.26
Hikal Ltd.	HIKAL	2,862.43	0	2.29	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,652.52	40.87	8.32	28.21	26.35
Beta Drugs Ltd.	BETA	2,623.92	67.31	10.65	18.65	22.17
Panacea Biotec Ltd.	PANACEABIO	2,571.92	0	3.06	0	5.36

SAI LIFE SCIENCES LIMITED (SAILIFE) has a market capitalisation of Rs 29,580.11 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The supplied peer set shows why SAI LIFE SCIENCES LIMITED Share Price remains notable even after today’s decline: the company’s market capitalisation of Rs 29,580.11 crore is still far above every listed peer shown in the comparison basket. Dishman Carbogen Amcis Ltd. is the largest peer listed at Rs 3,060.41 crore, followed by Hikal Ltd. at Rs 2,862.43 crore, Kwality Pharmaceuticals Ltd. at Rs 2,652.52 crore and Beta Drugs Ltd. at Rs 2,623.92 crore. That means SAI LIFE SCIENCES LIMITED is nearly an order of magnitude larger than the biggest peer in the supplied comparison set.

Looking at valuation and profitability across peers, the Healthcare basket is mixed rather than one-directional. Dishman Carbogen Amcis trades at a P/E of 31.3 with P/B of 0.46, but its ROE is -2.89 and ROCE is -0.26. Kwality Pharmaceuticals carries a P/E of 40.87 and P/B of 8.32, alongside ROE of 28.21 and ROCE of 26.35. Beta Drugs shows P/E of 67.31, P/B of 10.65, ROE of 18.65 and ROCE of 22.17. NGL Fine-Chem has P/E of 44.1, P/B of 6.45, ROE of 27.9 and ROCE of 33.91.

Other peers add more dispersion. Hikal’s P/B is 2.29 with ROE of 15.22 and ROCE of 16.15. Panacea Biotec’s P/B is 3.06 with ROE of 0 and ROCE of 5.36. Solara Active Pharma Sciences has P/B of 1.93, ROE of 17.23 and ROCE of 15.34. Sai Parenteral’s shows P/E of 167.74, P/B of 3.1, ROE of 13.9 and ROCE of 12.97, while Fredun Pharmaceuticals trades at P/E of 46.11, P/B of 6.89, ROE of 11.42 and ROCE of 13.15.

The main conclusion from this peer comparison is not that SAI LIFE SCIENCES LIMITED Share Price should mirror any one peer, but that the listed Healthcare universe includes sharply different combinations of valuation and return metrics. For Univest users following SAI LIFE SCIENCES LIMITED Stock Analysis, today’s share price decline is therefore best viewed alongside the company’s exceptional market size relative to this peer basket, rather than as a stand-alone price event.

Why Investors Are Watching SAI LIFE SCIENCES LIMITED

Investors are watching SAI LIFE SCIENCES LIMITED Share Price because the stock has recorded a clear same-day decline of 4.21% in a large-cap counter, while also showing an intraday pattern that remained under pressure after the open. In market terms, that combination is enough to move the stock into active discussion across Stocks in News, Top Losers Today and broader market update screens.

• Verified price action: The stock fell Rs 59.65 from Rs 1,415.25 to Rs 1,355.6, after opening at Rs 1,360.75 and touching a low of Rs 1,319.3.
• Trading participation: Total volume was 1,13,091 shares and turnover reached Rs 1.59 crore, showing measurable trading interest during the decline.
• Market size: The company’s market capitalisation is Rs 29,580.11 crore, making the move notable within the listed Healthcare space.
• Sector context: The Healthcare benchmark covers 198 companies, yet the benchmark maximum market cap is only Rs 3,060.41 crore, far below this company’s size.
• Peer positioning: The supplied peer basket shows wide variation in P/E, P/B, ROE and ROCE, reinforcing that comparative context matters.

What investors may monitor next is whether SAI LIFE SCIENCES LIMITED Share Price stabilises closer to the session low of Rs 1,319.3 or reclaims levels nearer the previous close and opening zone. On Univest, the most relevant follow-up is to track whether the stock remains among market movers, how trading activity evolves across NSE and BSE, and whether the broader Healthcare sector data continues to frame the stock as an outlier on market size.

About SAI LIFE SCIENCES LIMITED

SAI LIFE SCIENCES LIMITED is identified in the supplied dataset as part of the Healthcare sector. That sector label is the clearest verified business context available in the current feed, and it places the company within a listed universe that includes pharmaceuticals and drugs businesses as well as hospital and healthcare services names. For readers seeking SAI LIFE SCIENCES LIMITED Company News, this means the stock is being assessed within one of the market’s broad healthcare-oriented clusters rather than in isolation.

The benchmark companies associated with the same sector include pharmaceutical names such as Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Solara Active Pharma Sciences, Sai Parenteral’s, Fredun Pharmaceuticals and NGL Fine-Chem, along with Dr Agarwals Eye Hospital from hospital and healthcare services. That benchmark mix shows that Healthcare, as represented in the supplied data, spans multiple sub-segments with different business models and valuation structures.

For SAI LIFE SCIENCES LIMITED Share Price, the main verified corporate takeaway is that the company sits inside a broad Healthcare market ecosystem but with a market capitalisation of Rs 29,580.11 crore that is much larger than any benchmark company listed in the supplied sector set. In practical terms, that means investors tracking SAI LIFE SCIENCES LIMITED Latest News and SAI LIFE SCIENCES LIMITED Shareholding Pattern on research platforms are often likely to assess the stock through a combination of sector classification, listed scale and comparative market standing.

Track SAI LIFE SCIENCES LIMITED Share Price on Univest

Use SAI LIFE SCIENCES LIMITED (SAILIFE) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Univest helps investors track SAI LIFE SCIENCES LIMITED Share Price through a data-led market view that brings daily price action, market cap context and comparative stock analysis into one place. For readers following SAI LIFE SCIENCES LIMITED Share Price Today, SAI LIFE SCIENCES LIMITED Stock News and SAI LIFE SCIENCES LIMITED Share Price Update, the key advantage is that the stock can be monitored across live price movement, exchange-wise trading activity, sector benchmark context and peer comparison without relying on market noise.

On Univest, users can follow live share price, 52-week levels when available, market insights, technical indicators when supplied, fundamental ratios when supplied, sector analysis, company financial context and shareholding pattern disclosures. For a stock that has entered today’s market news cycle as a top decliner, keeping the data view organised is often more useful than reacting to the headline move alone.

Frequently Asked Questions

What is the SAI LIFE SCIENCES LIMITED Share Price Today?

Ans. SAI LIFE SCIENCES LIMITED Share Price Today was Rs 1,355.6 at the time of the update. The stock was down Rs 59.65 from the previous close of Rs 1,415.25, translating into a 4.21% single-session decline.

Why is SAI LIFE SCIENCES LIMITED Share Price falling today?

Ans. The supplied data confirms that SAI LIFE SCIENCES LIMITED Share Price fell 4.21% today and became a top decliner in the screen. However, the dataset establishes the price event itself and trading details, not a company-specific catalyst behind it.

What were the day high and day low for SAI LIFE SCIENCES LIMITED?

Ans. The stock opened at Rs 1,360.75, which was also the day’s high, and it later touched a low of Rs 1,319.3. That pattern suggests the session stayed under pressure after the opening print.

How much did SAI LIFE SCIENCES LIMITED fall from the previous close?

Ans. SAI LIFE SCIENCES LIMITED declined by Rs 59.65 from the previous close of Rs 1,415.25 to Rs 1,355.6. In percentage terms, that equals a 4.21% share price fall during the session covered in this update.

What is the market capitalisation of SAI LIFE SCIENCES LIMITED?

Ans. The company’s market capitalisation stands at Rs 29,580.11 crore. That makes it much larger than the Healthcare benchmark median of Rs 140.58 crore and also above the benchmark average of Rs 471.12 crore.

How active was trading in SAI LIFE SCIENCES LIMITED today?

Ans. Trading activity included total volume of 1,13,091 shares and turnover of Rs 1.59 crore. NSE volume was 1,01,340 shares, while BSE volume was 11,751 shares, showing participation across both exchanges during the decline.

Which sector does SAI LIFE SCIENCES LIMITED belong to?

Ans. SAI LIFE SCIENCES LIMITED is classified under the Healthcare sector in the supplied dataset. The benchmark scope covers 198 companies in the same sector, spanning pharmaceutical and healthcare-service names with widely differing valuations and return metrics.

How does SAI LIFE SCIENCES LIMITED compare with the Healthcare sector on size?

Ans. On size, the company stands out sharply. Its market cap is Rs 29,580.11 crore, while the benchmark maximum shown for 198 Healthcare companies is Rs 3,060.41 crore, highlighting a much larger listed equity value.

Which peers are included in the comparison for SAI LIFE SCIENCES LIMITED?

Ans. The supplied peer list includes Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Panacea Biotec, Dr Agarwals Eye Hospital, Solara Active Pharma Sciences, Sai Parenteral’s, Fredun Pharmaceuticals and NGL Fine-Chem.

Why is SAI LIFE SCIENCES LIMITED in focus on Univest today?

Ans. Univest is tracking the stock because SAI LIFE SCIENCES LIMITED Share Price fell 4.21% in a large-cap counter, with Rs 1.59 crore turnover and 1,13,091 shares traded, making it relevant in today’s market movers and stock updates.